| Meyya Meyyappan, PhD, Director, Center for Nanotechnology, NASA-Ames |
|
| Meyya
Meyyappan is Director of the Center for Nanotechnology as well as
Senior Scientist at NASA Ames Research Center in Moffett Field, CA.
He is a member of the Interagency Working Group on Nanotechnolgy (IWGN)
established by the Office of Science and Technolgy Policy(OSTP). The
IWGN is responsible for putting together the National Nanotechnolgy
Initiative. He is a member of IEEE, AIChE, AVS, ECS, and MRS. He is
the IEEE Distinquished Lecturer on Nanotechnology and ASME's Distinquished
Lecturer on Nanotechnology. |
Meyya Meyyappan |
| Dr. Soane is Chairman of Alnis BioSciences, ZMS, LLC and Founder and Chief Science Officer of Nano-Tex, LLC. Prior he was the Co-founder of ACLARA BioSciences , Inc. (NASDAQ: ACLA) (formerly Soane BioSciences). Previously he founded ZMS, LLC. Before that he founded Alnis BioSciences, Inc. Most recently he serves as president & CEO of Cosmetica, Inc., (Nanotechnology applications in personal care products) Soane was Professor of Chemical Engineering at U.C. Berkeley from 1979 to 1994, has authored more than 200 scientific papers and two books, and approximately 100 patents/patent applications. He received a B.S. degree in Chemistry from National Taiwan University and a Ph.D. in Chemical Engineering from U.C. Berkeley. |
David Soane |
| Jeffrey L. Cleland, Ph. D, VP Research & Development, Targesome |
|
| During
his 11 years at Genentech prior to joining Targesome, Dr. Cleland led
the development of Nutropin Depot from concept to approval and co-led
the manufacturing subteam for Herceptin through approval in both the
US and Europe. He obtained his Ph. D. in chemical engineering from M.I.T.
and is an adjunct assistant professor at the University of Colorado,
the University of Kansas, and the University of Pacific. He is an author
on over 90 manuscripts and serves on the editorial board of 5 journals
in the field of pharmaceutical sciences. His contributions to pharmaceutical
sciences have been internationally recognized by his election as a Fellow
of the American Association of Pharmaceutical Sciences and the International
Controlled Release Society Young Investigator Award for Excellence in
Research. |
Jeffrey L. Cleland |
| Lee Bruno , Section Editor, Briefings , Red Herring Communications |
|
| Lee
Bruno is Technology Editor at Red Herring magazine and writes an online
column called Lab Rat twice a month that reports on the most compelling
research and development taking place in large and small corporate labs
and prestigious universities. He has been reporting and writing about
technology for the past 14 years. Prior to joining Red Herring in November
1999, he was a senior editor covering networking technologies at Data
Communications magazine. He has appeared on CNN and radio programs,
providing commentary on technology and business issues. Mr. Bruno graduated
with a bachelor's degree in biology from San Francisco State University
and received a master's degree in journalism from Boston University.
|
Lee Bruno |
| Alexander Wong Ph.D, Partner, Apax Partners |
|
| Alexander Wong focuses on semiconductor, optical and emerging technology investments. Previously, he was a Managing Director at Intel Capital, where he led the technology group responsible for investment and mergers and acquisitions activity in semiconductors and emerging technologies. Dr. Wong has also served as Chief of Staff to the President of Intel Capital. Dr. Wong holds Ph.D. and M.S. degrees in Electrical Engineering from the University of California at Berkeley, as well as a B.S. degree in Computer Engineering from the University of Illinois |
|
| Alan Marty, Executive-in-Residence, JPMorgan Partners |
|
| Alan Marty is responsible for driving the JPMorgan investments in the nanotechnology arena. Mr. Marty brings both a business and technology perspective on nanotechnology. While at Hewlett-Packard, Mr. Marty was General Manager of the Integrated Circuit Business with responsibility for all aspects of the multi-national enterprise. At Agilent Technologies, Mr. Marty was General Manager of the Microdisplay Business, an early entrant into commercialized nanotechnology. Early in his career, Mr. Marty was an Associate Professor in Materials Science as Silliman University and served as a White House Fellow during the Bush administration in 1989. Mr. Marty received his bachelor's degree in Materials Science from Iowa State University and an MBA from Stanford University. |
Alan Marty |
| Allan May,chairman investment screening committee,Tenex Medical |
|
| Mr. May has been a Founder, board member or Chairman and CEO of a number of early stage companies in the life sciences, eHealth and Internet arenas including Intella Interventional Systems, MAST Immunosystems, ImmuneTech and more. In addition to investment activities, Mr. May has an extensive background in negotiating mergers, acquisitions, strategic transactions and alliances. His transactions have involved public and private companies, domestic and international, principally in the life science and high technology sectors. Mr. May lectures frequently on trends and developments affecting life science investing. Mr. May received his Juris Doctorate from Case Western Reserve University. He received his Bachelor of Arts degree in 1969 from Kent State University. He is also a graduate of the Stanford Executive Program for Small Business. |
Allan May |
| Ed Niehaus, Business and marketing consultant |
|
| Ed Niehaus was CEO of Niehaus Ryan Wong, Inc., the public relations agency that launched VeriSign, Yahoo, Apple Computer's iMac and other legendary brands. Ed was co-founder of the Nanotechnology Opportunity Report, and serves on its advisory board, and on those of the Institute for Molecular Manufacturing and the Software Development Forum. Ed is a long-time advisor to Foresight Institute, pursuing a 15 year interest in nanotechnology. Prior to NRW, Ed served in a several marketing and sales capacities in the computer and softwareindustries. Ed has a BSME degree from Duke University and is a licensed Professional Engineer. |
Ed Niehaus |
| Zeljka Matutinovic Ph.D, General Partner, Jerusalem Venture Partners | |
Zeljka Matutinovic co-heads JVP’s activities in North America. She is a board member of several JVP companies, including Mahi, Quarry, Kovio and Renka. Previously, Ms. Matutinovic was Managing Director at International Real Returns. Ms. Matutinovic also worked in the Investment Banking/Technology Group at Credit Suisse First Boston. Prior to this, Ms. Matutinovic was a consultant at McKinsey & Company, a Research and Teaching Assistant at Princeton University and also held the position of Junior Assistant Professor at the School of Electrical Engineering at the University of Zagreb. Ms. Matutinovic holds a Ph.D. in Electrical Engineering and an M.S. in Electrical Engineering from Princeton University, and an M.S. in Electrical Engineering and B.S. in Electrical Engineering from the University of Zagreb. |
Zeljka Matutinovic |
Alex
Wong
